Inventurus Knowl

Inventurus Knowledge Solutions (IKS) is undergoing a strategic pivot to IKS 3.0, driven by macro trends in US healthcare, including declining reimbursement (down 54% adjusted for inflation since 2001), ineffective physician aggregation, and underperforming value-based care models. The company observed that physician aggregations, despite 69% of US physicians being employed, have not significantly reduced costs, improved quality, or increased access. IKS 3.0 aims to address these challenges by moving beyond platform implementation to co-owning outcomes and participating in provider aggregation growth.

IKS has invested $17 million for a 48% ownership stake in the Managed Services Organization (MSO) of Western Washington Medical Group (WWMG), which has a pre-money valuation of $18.4 million. The MSO will manage all non-clinical functions for WWMG, a group with approximately 100 clinicians and nearly $100 million in revenue. This structure ensures that about 63% of WWMG's revenue flows to the MSO, covering operational costs and incorporating the IKS Care Enablement Platform.

The investment is designed to create two pools of economic value: traditional margins from IKS's platform implementation and participation in the MSO's growth and profitability. IKS expects an ROE of over 20% on this investment, aligning with its historical ROE of over 30%. The full IKS platform is expected to be implemented within the MSO in 3-6 months, with IKS platform-related revenue projected to be 10-12% of the MSO's top-line revenue. This model aims to deliver 850-900 basis points of EBITDA expansion for clients, potentially reaching 1100-1200 bps with holistic implementation.

IKS maintains a conservative capital allocation strategy, avoiding equity dilution and excessive leverage. The company's net debt has been reduced to nearly half of its peak of $117 million. The $17 million investment in WWMG's MSO is primarily allocated to physician growth and expanding clinic facilities, rather than cashing out existing physicians. This approach ensures alignment with growth objectives and long-term value creation.

The WWMG MSO will serve as a 'live lab' for the continuous evolution of the IKS platform, particularly for integrating with Epic EHR and co-creating new features. Management intends to selectively pursue similar strategic partnerships, focusing on opportunities that meet criteria for execution capability, capital prudence, and ROE targets. This strategy aims to accelerate the proliferation of IKS's platform and establish it as a unique transformation enabler in the healthcare industry.